Jacquie Astemborski

10.4k total citations · 2 hit papers
115 papers, 7.2k citations indexed

About

Jacquie Astemborski is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Jacquie Astemborski has authored 115 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Epidemiology, 50 papers in Hepatology and 34 papers in Infectious Diseases. Recurrent topics in Jacquie Astemborski's work include Hepatitis C virus research (50 papers), HIV, Drug Use, Sexual Risk (34 papers) and HIV Research and Treatment (33 papers). Jacquie Astemborski is often cited by papers focused on Hepatitis C virus research (50 papers), HIV, Drug Use, Sexual Risk (34 papers) and HIV Research and Treatment (33 papers). Jacquie Astemborski collaborates with scholars based in United States, Israel and China. Jacquie Astemborski's co-authors include David Vlahov, David L. Thomas, Shruti H. Mehta, Gregory D. Kirk, Steffanie A. Strathdee, Chloe L. Thio, Kenrad E. Nelson, Stephen J. O’Brien, Noya Galai and James J. Goedert and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Jacquie Astemborski

114 papers receiving 7.0k citations

Hit Papers

HLA and NK Cell Inhibitory Receptor Genes in Resolving He... 2000 2026 2008 2017 2004 2000 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
    2004 906 citations Chloe L. Thio, Jacquie Astemborski et al. profile →
  2. The Natural History of Hepatitis C Virus Infection
    2000 841 citations Jacquie Astemborski, Steffanie A. Strathdee et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacquie Astemborski United States 44 4.6k 3.5k 2.0k 1.5k 1.2k 115 7.2k
Janaki Amin Australia 48 3.3k 0.7× 2.3k 0.7× 2.5k 1.3× 559 0.4× 1.7k 1.4× 217 7.0k
Andrew H. Talal United States 35 2.6k 0.6× 2.9k 0.8× 1.2k 0.6× 1.0k 0.7× 1.3k 1.1× 141 5.1k
Margaret James Koziel United States 42 4.4k 1.0× 5.1k 1.5× 1.1k 0.6× 1.4k 0.9× 797 0.7× 98 6.8k
Chloe L. Thio United States 50 6.7k 1.5× 6.7k 1.9× 2.0k 1.0× 1.8k 1.3× 795 0.7× 154 9.4k
Massimo Puoti Italy 47 6.6k 1.4× 7.0k 2.0× 2.5k 1.2× 479 0.3× 651 0.5× 263 9.1k
Angelos Hatzakis Greece 43 4.7k 1.0× 3.4k 1.0× 2.5k 1.2× 297 0.2× 932 0.8× 221 7.0k
Juan González‐Lahoz Spain 40 2.3k 0.5× 1.7k 0.5× 2.6k 1.3× 391 0.3× 1.7k 1.5× 172 4.9k
Arthur Y. Kim United States 38 2.7k 0.6× 3.3k 0.9× 1.2k 0.6× 1.1k 0.7× 658 0.5× 121 4.9k
Pier‐Angelo Tovo Italy 42 1.9k 0.4× 833 0.2× 1.8k 0.9× 1.1k 0.8× 1.2k 1.0× 190 5.0k
Dominique Salmon‐Céron France 35 2.2k 0.5× 1.1k 0.3× 2.0k 1.0× 430 0.3× 931 0.8× 161 4.8k

Countries citing papers authored by Jacquie Astemborski

Since Specialization
Citations

This map shows the geographic impact of Jacquie Astemborski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacquie Astemborski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacquie Astemborski more than expected).

Fields of papers citing papers by Jacquie Astemborski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacquie Astemborski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacquie Astemborski. The network helps show where Jacquie Astemborski may publish in the future.

Co-authorship network of co-authors of Jacquie Astemborski

This figure shows the co-authorship network connecting the top 25 collaborators of Jacquie Astemborski. A scholar is included among the top collaborators of Jacquie Astemborski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacquie Astemborski. Jacquie Astemborski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, David L., Gregory D. Kirk, Shruti H. Mehta, et al.. (2024). Hepatitis B Virus DNA and RNA Persist in Liver After Serologic Recovery in Persons With Hepatitis C Virus. The Journal of Infectious Diseases. 230(6). 1352–1356. 1 indexed citations
2.
Patel, Eshan U., Jacquie Astemborski, Kenneth A. Feder, et al.. (2023). Temporal association of pre-pandemic perceived social support with psychological resilience and mental well-being during the COVID-19 pandemic among people with a history of injection drug use. Drug and Alcohol Dependence. 244. 109802–109802. 3 indexed citations
3.
Cepeda, Javier, Jacquie Astemborski, Kenneth A. Feder, et al.. (2023). Time-to-completion of COVID-19 vaccination primary series varies by HIV viral load status among people who inject drugs in Baltimore, Maryland. Preventive Medicine Reports. 36. 102448–102448. 4 indexed citations
4.
Dias, Jenny Pena, Damani A. Piggott, Jing Sun, et al.. (2022). SHBG, Bone Mineral Density, and Physical Function Among Injection Drug Users With and Without HIV and HCV. The Journal of Clinical Endocrinology & Metabolism. 107(7). e2971–e2981. 5 indexed citations
5.
Sun, Jing, Shruti H. Mehta, Jacquie Astemborski, et al.. (2021). Mortality among people who inject drugs: a prospective cohort followed over three decades in Baltimore, MD, USA. Addiction. 117(3). 646–655. 17 indexed citations
6.
Genberg, Becky L., Jacquie Astemborski, Glenn J. Treisman, et al.. (2019). Engagement in treatment for depression among people who inject drugs in Baltimore, Maryland. Journal of Substance Abuse Treatment. 106. 107–112. 17 indexed citations
7.
Falade‐Nwulia, Oluwaseun, Eshan U. Patel, Shruti H. Mehta, et al.. (2019). Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore. Infection Genetics and Evolution. 77. 104078–104078. 6 indexed citations
8.
Buresh, Megan, Becky L. Genberg, Jacquie Astemborski, Gregory D. Kirk, & Shruti H. Mehta. (2019). Recent fentanyl use among people who inject drugs: Results from a rapid assessment in Baltimore, Maryland. International Journal of Drug Policy. 74. 41–46. 34 indexed citations
9.
Islam, Salequl, Damani A. Piggott, Alberto Moriggia, et al.. (2019). Reducing injection intensity is associated with decreased risk for invasive bacterial infection among high-frequency injection drug users. Harm Reduction Journal. 16(1). 38–38. 21 indexed citations
10.
Lambert, Allison, Gregory D. Kirk, Jacquie Astemborski, et al.. (2014). A Cross Sectional Analysis of the Role of the Antimicrobial Peptide Cathelicidin in Lung Function Impairment within the ALIVE Cohort. PLoS ONE. 9(4). e95099–e95099. 16 indexed citations
11.
Drummond, Michael, Gregory D. Kirk, Jacquie Astemborski, et al.. (2011). Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax. 67(4). 309–314. 74 indexed citations
12.
Thio, Chloe L., Jacquie Astemborski, Arman Bashirova, et al.. (2006). Genetic Protection against Hepatitis B Virus Conferred by CCR5Δ32 : Evidence that CCR5 Contributes to Viral Persistence. Journal of Virology. 81(2). 441–445. 62 indexed citations
13.
Mehta, Shruti H., Jacquie Astemborski, Timothy R. Sterling, David L. Thomas, & David Vlahov. (2006). Serum Albumin as a Prognostic Indicator for HIV Disease Progression. AIDS Research and Human Retroviruses. 22(1). 14–21. 52 indexed citations
14.
Kelleher, Thomas, Shruti H. Mehta, R. Bhaskar, et al.. (2005). Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: The SHASTA index. Journal of Hepatology. 43(1). 78–84. 171 indexed citations
15.
Golub, Elizabeth T., Jacquie Astemborski, Donald R. Hoover, et al.. (2003). Psychological Distress and Progression to AIDS in a Cohort of Injection Drug Users. JAIDS Journal of Acquired Immune Deficiency Syndromes. 32(4). 429–434. 37 indexed citations
16.
Astemborski, Jacquie, et al.. (2001). Isoniazid Preventive Therapy, Hepatitis C Virus Infection, and Hepatotoxicity among Injection Drug Users Infected withMycobacterium tuberculosis. Clinical Infectious Diseases. 33(10). 1687–1691. 47 indexed citations
17.
Sterling, Timothy R., David Vlahov, Jacquie Astemborski, et al.. (2001). Initial Plasma HIV-1 RNA Levels and Progression to AIDS in Women and Men. New England Journal of Medicine. 344(10). 720–725. 260 indexed citations
18.
Inglesby, Thomas V., Rudra Rai, Jacquie Astemborski, et al.. (1999). A Prospective, Community–Based Evaluation of Liver Enzymes in Individuals With Hepatitis C After Drug Use. Hepatology. 29(2). 590–596. 66 indexed citations
19.
Sterling, Timothy R., Richard D. Moore, Neil M.H. Graham, et al.. (1998). Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease. AIDS. 12(12). 1451–1457. 7 indexed citations
20.
Farzadegan, Homayoon, David Vlahov, Álvaro Muñoz, et al.. (1993). Detection of Human Immunodeficiency Virus Type 1 Infection by Polymerase Chain Reaction in a Cohort of Seronegative Intravenous Drug Users. The Journal of Infectious Diseases. 168(2). 327–331. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janaki Amin Breakdown of academic impact, for papers by Andrew H. Talal Breakdown of academic impact, for papers by Margaret James Koziel Breakdown of academic impact, for papers by Chloe L. Thio Breakdown of academic impact, for papers by Massimo Puoti Breakdown of academic impact, for papers by Angelos Hatzakis Breakdown of academic impact, for papers by Juan González‐Lahoz Breakdown of academic impact, for papers by Arthur Y. Kim Breakdown of academic impact, for papers by Pier‐Angelo Tovo Breakdown of academic impact, for papers by Dominique Salmon‐Céron
Rankless by CCL
2026